A detailed history of Fiduciary Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fiduciary Family Office, LLC holds 29,602 shares of BMY stock, worth $1.65 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
29,602
Previous 24,961 18.59%
Holding current value
$1.65 Million
Previous $1.04 Billion 47.75%
% of portfolio
0.51%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$39.66 - $51.75 $184,062 - $240,171
4,641 Added 18.59%
29,602 $1.53 Billion
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $436,269 - $574,358
-10,839 Reduced 30.28%
24,961 $1.04 Billion
Q1 2024

May 07, 2024

BUY
$47.98 - $54.4 $893,243 - $1.01 Million
18,617 Added 108.35%
35,800 $1.94 Billion
Q4 2023

May 07, 2024

BUY
$48.48 - $57.85 $833,031 - $994,036
17,183 New
17,183 $882 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fiduciary Family Office, LLC Portfolio

Follow Fiduciary Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Family Office, LLC with notifications on news.